AI-ECG Tracker vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose AI-ECG Tracker if…
Choose AI-ECG Tracker if your practice requires comprehensive, high-accuracy AI-powered analysis of full 12-lead ECG data for a wide spectrum of cardiac abnormalities. This tool is ideal for settings needing rapid, detailed diagnostic support for conditions like arrhythmias, myocardial ischemia, and infarction, with robust on-premise processing capabilities.
View AI-ECG Tracker →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your goal is to integrate an early, non-invasive screening tool for heart failure risk into routine physical examinations. This solution is best suited for clinicians looking to leverage digital stethoscopes to quickly identify patients with potential low ejection fraction, aiding in proactive heart care.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-ECG Tracker | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Deployment | Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities. | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Tool B (Eko Low Ejection Fraction Tool) offers a more immediate and integrated point-of-care experience by leveraging familiar digital stethoscopes for rapid screening during routine physical exams. While Tool A (AI-ECG Tracker) provides faster diagnosis (3 seconds), its on-premise workstation and dedicated client suggest a more specialized workflow compared to Tool B's seamless integration into general physical exams.
Clinical Value
Eko Low Ejection Fraction Tool (ELEFT)Both tools are FDA-cleared and offer significant clinical value. Tool A provides comprehensive ECG analysis for a broad range of abnormalities with high reported accuracy. However, Tool B is specifically designed for the early detection of low ejection fraction, a critical indicator of heart failure, and is supported by prospective multicenter clinical validation studies demonstrating specific sensitivity and specificity.
Pricing & Value
Eko Low Ejection Fraction Tool (ELEFT)Neither tool provides publicly available pricing, making a direct cost comparison impossible. However, Tool B, as part of the SENSORAu2122 platform, has established a clear pathway for reimbursement through CMS recognition and anticipated CPT codes, enhancing its value proposition for healthcare providers by enabling cost recovery. Tool A lacks this transparency regarding reimbursement mechanisms.
Enterprise Readiness
Eko Low Ejection Fraction Tool (ELEFT)Both tools demonstrate strong enterprise readiness. Tool A offers flexible deployment options (on-premise and cloud) and is backed by a global company. Tool B explicitly positions itself as an 'enterprise solution,' is cloud-native, and provides clear statements on HIPAA compliance and BAA, along with dedicated enterprise support resources.
Innovation
Eko Low Ejection Fraction Tool (ELEFT)While Tool A is innovative in its high-accuracy, rapid, and comprehensive ECG analysis, Tool B demonstrates a more disruptive innovation. By integrating an AI algorithm with a ubiquitous clinical tool like the stethoscope for early, non-invasive heart failure detection at the point of care, Tool B significantly democratizes access to advanced cardiac screening.
Support & Docs
Eko Low Ejection Fraction Tool (ELEFT)Tool B (Eko Low Ejection Fraction Tool) provides a well-defined support structure, including a dedicated SENSORAu2122 Help Center for enterprise users, multiple contact channels (email, phone, chat), and comprehensive documentation like user manuals and FAQs. While Tool A's parent company offers general support, specific support details for the AI-ECG Tracker product are less explicit.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-ECG Tracker | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Company | Shenzhen Carewell Electronics Co. | Eko Health |
| Tagline | Forever Innovation Forever Care! | Your new partner in precise, proactive heart and lung care. |
| Key Functionality | AI-powered ECG auto-analysis and diagnosis for 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. Supports 12-lead ECG data collection. | AI-powered low ejection fraction detection by analyzing ECG and heart sound recordings, integrated with FDA-cleared Eko digital stethoscopes. |
| Diagnosis Speed | Approximately 3 seconds | Approximately 15 seconds |
| Specialties | Array | Array |
Videos
Demos, reviews, and walkthroughs featuring AI-ECG Tracker and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring AI-ECG Tracker or Eko Low Ejection Fraction Tool (ELEFT)
Backers
Who funded each tool's parent company.